Expressions of Topoisomerase IIα and BCRP in Metastatic Cells are Associated with Overall Survival in Small Cell Lung Cancer Patients-Reference-Cited by-同舟云学术

Expressions of Topoisomerase IIα and BCRP in Metastatic Cells are Associated with Overall Survival in Small Cell Lung Cancer Patients

Published:2011-04-01 Issue:3 Volume:17 Page:691-696
ISSN:1219-4956
Container-title:Pathology & Oncology Research
language:en
Short-container-title:Pathol. Oncol. Res.

Author:

Rijavec Matija,Šilar Mira,Triller Nadja,Kern Izidor,Čegovnik Urška,Košnik Mitja,Korošec Peter

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine,Pathology and Forensic Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12253-011-9370-2.pdf

Reference23 articles.

1. National Comprehensive Cancer Network, Clinical Practice Guidelines in Oncology: Small cell lung cancer. Available at: http://www.nccn.org/professionals/physician_gls/PDF/sclc.pdf . Accessed June 3, 2009

2. National Comprehensive Cancer Network, Clinical Practice Guidelines in Oncology: Non-Small cell lung cancer. Available at: http://www.nccn.org/professionals/physician_gls/PDF/nscl.pdf . Accessed June 3, 2009

3. Scagliotti GV, Novello S, Selvaggi G (1999) Multidrug resistance in non-small-cell lung cancer. Ann Oncol 10:S83–S86

4. Smith EF, Postmus PE (1995) Chemotherapy of small cell lung cancer. In: Carney DN (ed) lung cancer. The Bath Press, Avon, pp 156–172

5. Ihde DC, Minna JD (1991) Non-small cell lung cancer. Part I: biology, diagnosis, and staging. Curr Probl Cancer 15:61–104

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibitors of ABCB1 and ABCG2 overcame resistance to topoisomerase inhibitors in small cell lung cancer;Thoracic Cancer;2022-06-20

2. Flavonoid Monomers as Potent, Nontoxic, and Selective Modulators of the Breast Cancer Resistance Protein (ABCG2);Journal of Medicinal Chemistry;2021-10-04

3. Triazole Bridged Flavonoid Dimers as Potent, Nontoxic, and Highly Selective Breast Cancer Resistance Protein (BCRP/ABCG2) Inhibitors;Journal of Medicinal Chemistry;2019-08-29

4. The shifting paradigm of biomarker-driven care in advanced non-small cell lung cancer (NSCLC);Translational Lung Cancer Research;2019-08

5. Comparison of LC-MS/MS-based targeted proteomics and conventional analytical methods for monitoring breast cancer resistance protein expression;Life Sciences;2019-08